SCHEMBL23113691

SCHEMBL23113691

NC(=O)c1cnc(Cl)nc1Oc1c(F)c(F)cc(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ POLB P06746 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ PIN1 Q13526 2/20 0.36
▸ NNMT P40261 2/20 0.35
▸ NFKB1 P19838 4/20 0.34
▸ ATF1 P18846 3/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ XPO1 O14980 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ SCN9A Q15858 1/20 0.32
▸ CSF1R P07333 3/20 0.32
▸ NUDT1 P36639 1/20 0.32
▸ JUN P05412 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23113420 0.76 CAMK1D (0.47) ALDH1A1NNMTCSF1RIRAK4
SCHEMBL21596337 0.73 PIN1 (0.55) ALDH1A1POLBCASP6PIN1RAB9A
SCHEMBL30962568 0.73 NNMT (0.46) ALDH1A1GAAPOLBPIN1NNMT
SCHEMBL23113259 0.71 CAMK1D (0.55) CSF1R
SCHEMBL16670419 0.71 PIN1 (0.52) POLBCASP6PIN1SCN9ARAB9A
SCHEMBL30962756 0.71 NNMT (0.40) PIN1NNMTNFKB1CNR1LMNA
SCHEMBL29724129 0.67 NFKB1 (0.45) POLBNNMTNFKB1ATF1XPO1
SCHEMBL914000 0.67 NFKB1 (0.45) POLBNNMTNFKB1ATF1XPO1
SCHEMBL28874643 0.66 POLB (0.39) ALDH1A1GAAPOLBCASP6PIN1
SCHEMBL17673007 0.66 PIN1 (0.56) POLBPIN1CNR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530193-B2 Kinase inhibitors THE UNIVERSITY OF MANCHESTER (GB) 2022-12-20 — — US disclosed
EP-3793996-A1 KINASE INHIBITORS The University of Manchester (GB) 2021-03-24 — — EP disclosed
CN-112119077-A Kinase inhibitors 曼彻斯特大学 2020-12-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530193-B2 Kinase inhibitors CAMKK2, CAMK1, CAMKK1 ALDH1A1 2394/4885GAA 2326/4885POLB 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback